Search by Drug Name or NDC

    NDC 17856-0732-01 Cepacol 15; 2.6 mg/1; mg/1 Details

    Cepacol 15; 2.6 mg/1; mg/1

    Cepacol is a ORAL LOZENGE in the HUMAN OTC DRUG category. It is labeled and distributed by ATLANTIC BIOLOGICALS CORP.. The primary component is BENZOCAINE; MENTHOL.

    Product Information

    NDC 17856-0732
    Product ID 17856-0732_4e1fd22f-4112-4c6d-a707-27211ff2b814
    Associated GPIs
    GCN Sequence Number 067736
    GCN Sequence Number Description benzocaine/menthol LOZENGE 15MG-2.6MG MUCOUS MEM
    HIC3 H0A
    HIC3 Description LOCAL ANESTHETICS
    GCN 30355
    HICL Sequence Number 001675
    HICL Sequence Number Description BENZOCAINE/MENTHOL
    Brand/Generic Generic
    Proprietary Name Cepacol
    Proprietary Name Suffix Extra Strength Sore Throat honey lemon
    Non-Proprietary Name Benzocaine and Menthol
    Product Type HUMAN OTC DRUG
    Dosage Form LOZENGE
    Route ORAL
    Active Ingredient Strength 15; 2.6
    Active Ingredient Units mg/1; mg/1
    Substance Name BENZOCAINE; MENTHOL
    Labeler Name ATLANTIC BIOLOGICALS CORP.
    Pharmaceutical Class Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part356
    Listing Certified Through 2023-12-31

    Package

    NDC 17856-0732-01 (17856073201)

    NDC Package Code 17856-0732-1
    Billing NDC 17856073201
    Package 50 POUCH in 1 BOX (17856-0732-1) / 1 LOZENGE in 1 POUCH (17856-0732-2)
    Marketing Start Date 2022-09-14
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 08160ced-e19b-443e-ab16-0d3e4ae8a8ab Details

    Revised: 9/2022